M. L. García-Alcalde

Bacterial Meningitis in HIV-1-Infected Patients in the Era of Highly Active Antiretroviral Therapy

F. Vidal, E. Ribera, J. Cosín, 2009, Journal of acquired immune deficiency syndromes.

Characteristics and outcome of HIV infection in gypsies in the Spanish VACH Cohort.

F. Vidal, E. Ribera, J. Cosín, 2010, Enfermedades Infecciosas y Microbiologia Clinica.

Factors Associated with Liver Fibrosis in Intravenous Drug Users Coinfected with HIV and HCV

J. Carton, V. Asensi, J. Collazos, 2011, Antiviral therapy.

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.

F. Vidal, E. Ribera, M. Crespo, 2008, The Journal of antimicrobial chemotherapy.

[Ergotism in a patient treated with ritonavir and ergotamine].

B. de la Fuente, M. L. García-Alcalde, C. Gallo, 2002, Medicina clinica.

[Infection due to herpes zoster and cryptococcus after initiating high-activity antiretroviral treatment].

F. J. Nuño, M. L. García-Alcalde, E. M. Fonseca, 2003, Enfermedades Infecciosas y Microbiologia Clinica.

Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort).

E. Ribera, J. Arribas, J. Cosín, 2002, AIDS.

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.

F. Vidal, E. Ribera, M. Crespo, 2008, The Journal of antimicrobial chemotherapy.

Dyslipidemia and Cardiovascular Disease Risk Factor Management in HIV-1-Infected Subjects Treated with HAART in the Spanish VACH Cohort

E. Ribera, J. Cosín, P. Viciana, 2008, The open AIDS journal.